Tagged with Intellectual Property

Milind Antani – Lead, Pharma, Life Science and Healthcare Practice; Head, Social Sector Practice, Nishith Desai Associates
How Patent Analytics Can Show Pharma’s Top Performers
Charles Gore – Executive Director, Medicines Patent Pool (MPP)
Pharma Industry Leaders Lambast IP Waivers & Weigh In on Vaccine Inequity
IP in Saudi Arabia: Room for Improvement?
The WHO Pandemic Treaty & Three Key Lessons from the COVID-19 Response
Mexico: Despite Hurdles, Pharma Market Remains Attractive
Interview: Sergio Olivares – Managing Director, Olivares, Mexico
Interview: Leonardo Vingiani – Director, ASSOBIOTEC, Italy
Interview: Agustín Rullán – Dean, College of Engineering, UPR Mayagüez, Puerto Rico
Interview: Dr. Boonchai Somboonsook, Secretary General of the Thai FDA and Mrs. Yuppadee Javroongrit, Senior Expert on Pharmaceuticals Standard, Food & Drug Administration, Thailand
Berken IP – Alicia Alvarez Berkenwald, Managing Partner and Patent Analyst – Argentina
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here